Diligence memo · auto-generated · as of July 2, 2026
Genetics Squared, Inc.
Genetics Squared, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Genetics Squared, Inc. operates in Other Health Care, based in ANN ARBOR.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Genetics Squared, Inc. has raised $821K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $821K on 2009-09-29.
Most recent recorded round closed around 2009-09-29.
Valuation (modeled)modeled
Provath models Genetics Squared, Inc. at approximately $25M (range $514K–$287M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.45× the median modeled value of Pre-Seed Other Health Care companies in 2007–2009 (128 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 16.8 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 30% of Other Health Care peers (5377 compared).
Modeled value ranks above 53% of those peers.
Closest niche peers: Enject Inc, Aspyra Inc, Active Day, Inc., Explainmysurgery.Com, Sutter Fairfield Surgery Center, LLC.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.